Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Bioequivalence Study of Dabigatran Etexilate Capsules under Fasting Conditions
TCTR20210819001Phase 1Not yet recruiting
- Sponsor
- MSN Laboratories
- Start
- Nov 2021
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 1, randomised trial of dabigatran in venous thromboembolism (VTE) and Atrial fibrillation (AFib) (2 arms), sponsored by MSN Laboratories. Planned start Nov 2021; status: not yet recruiting.
02
Drugs
dabigatran
03
Conditions
venous thromboembolism (VTE)Atrial fibrillation (AFib)
Beyond the preview
Go deeper on TCTR20210819001.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on TCTR20210819001.